Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Lumeda
AddedFeb 15, 2024
UpdatedJun 18, 2026
Lumeda

Lumeda

Series A

Lumeda Inc.: Advancing photodynamic therapy for thoracic malignancies with our breakthrough product, DigiLum.

HQ
Rocky Hill, CT, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Founded to commercialize novel medical device technology, Lumeda Inc. focuses on advancing photodynamic therapy (PDT) for treating non-small cell lung cancer (NSCLC) and other thoracic malignancies. The company's core mission is to expand the use of PDT, a proven and safe therapy free of systemic toxicities, into new sites and indications. Lumeda's flagship product, DigiLum, is a breakthrough light dosimetry device designed to activate photosensitizer drugs, enhancing the efficacy of PDT and improving patient outcomes.

Lumeda has attracted notable investors and industry experts who support its innovative approach to cancer treatment. The company has achieved significant milestones, including the development and initial commercialization of DigiLum. Lumeda's impact lies in its potential to offer a safer, more effective therapeutic option for patients with thoracic malignancies, addressing a critical need in the oncology market and potentially improving survival rates and quality of life for many patients globally.

Lumeda - Similar Companies

LumiThera logo

LumiThera

lumithera.com

Luma Therapeutics logo

Luma Therapeutics

Photopharmics logo

Photopharmics

photopharmics.com

Luminate Medical logo

Luminate Medical

luminatemed.com

Lumenxt logo

Lumenxt

lumenxt.com

i-Lumen Scientific logo

i-Lumen Scientific

i-lumen.com

eLum Technologies logo

eLum Technologies

Lumedica logo

Lumedica

Lumed Science logo

Lumed Science

Luminopia logo

Luminopia

luminopia.com

OnLume logo

OnLume

onlume.com

Lumicell logo

Lumicell

lumicell.com

Light Line Medical logo

Light Line Medical

Photometics logo

Photometics

Pneuma Respiratory logo

Pneuma Respiratory

Lumeda - Quick Facts

Who are Lumeda's competitors?

Companies similar to Lumeda include LumiThera, Luma Therapeutics, Photopharmics and Luminate Medical.

When was Lumeda founded?

Lumeda was founded in 2020.

Where is Lumeda's headquarters located?

Lumeda's headquarters is located in Rocky Hill, CT, US.

When was Lumeda's last funding round?

Lumeda's most recent funding round was for $4.3M (USD) in April 2021.

How much has Lumeda raised to-date?

As of Apr 8, 2021, Lumeda has raised a total of $7.4M (USD).

How many employees does Lumeda have?

Lumeda has 11 employees as of Feb 5, 2024.

Lumeda - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified